Innovative Nanomedicine Delivery: Targeting Tumor Microenvironment to Defeat Drug Resistance

Nanodrug delivery systems have revolutionized tumor therapy like never before. By overcoming the complexity of the tumor microenvironment (TME) and bypassing drug resistance mechanisms, nanotechnology has shown great potential to improve drug efficacy and reduce toxic side effects. This review exami...

Full description

Saved in:
Bibliographic Details
Main Authors: Wenjun Meng, Li Huang, Jiamin Guo, Qing Xin, Jiyan Liu, Yuzhu Hu
Format: Article
Language:English
Published: MDPI AG 2024-12-01
Series:Pharmaceutics
Subjects:
Online Access:https://www.mdpi.com/1999-4923/16/12/1549
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846103189281046528
author Wenjun Meng
Li Huang
Jiamin Guo
Qing Xin
Jiyan Liu
Yuzhu Hu
author_facet Wenjun Meng
Li Huang
Jiamin Guo
Qing Xin
Jiyan Liu
Yuzhu Hu
author_sort Wenjun Meng
collection DOAJ
description Nanodrug delivery systems have revolutionized tumor therapy like never before. By overcoming the complexity of the tumor microenvironment (TME) and bypassing drug resistance mechanisms, nanotechnology has shown great potential to improve drug efficacy and reduce toxic side effects. This review examines the impact of the TME on drug resistance and recent advances in nanomedicine delivery systems to overcome this challenge. Characteristics of the TME such as hypoxia, acidity, and high interstitial pressure significantly reduce the effectiveness of chemotherapy and radiotherapy, leading to increased drug resistance in tumor cells. Then, this review summarizes innovative nanocarrier designs for these microenvironmental features, including hypoxia-sensitive nanoparticles, pH-responsive carriers, and multifunctional nanosystems that enable targeted drug release and improved drug penetration and accumulation in tumors. By combining nanotechnology with therapeutic strategies, this review offers a novel perspective by focusing on the innovative design of nanocarriers that interact with the TME, a dimension often overlooked in similar reviews. We highlight the dual role of these nanocarriers in therapeutic delivery and TME modulation, emphasize their potential to overcome drug resistance, and look at future research directions.
format Article
id doaj-art-4d410a8be0fc4fd2ae3ebae2a9fffb6a
institution Kabale University
issn 1999-4923
language English
publishDate 2024-12-01
publisher MDPI AG
record_format Article
series Pharmaceutics
spelling doaj-art-4d410a8be0fc4fd2ae3ebae2a9fffb6a2024-12-27T14:46:28ZengMDPI AGPharmaceutics1999-49232024-12-011612154910.3390/pharmaceutics16121549Innovative Nanomedicine Delivery: Targeting Tumor Microenvironment to Defeat Drug ResistanceWenjun Meng0Li Huang1Jiamin Guo2Qing Xin3Jiyan Liu4Yuzhu Hu5Department of Radiation Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu 610041, ChinaDepartment of Biotherapy, Cancer Center, West China Hospital, Sichuan University, Chengdu 610041, ChinaDivision of Abdominal Tumor Multimodality Treatment, Cancer Center, West China Hospital, Sichuan University, Chengdu 610041, ChinaDepartment of Radiation Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu 610041, ChinaDepartment of Biotherapy, Cancer Center, West China Hospital, Sichuan University, Chengdu 610041, ChinaDepartment of Radiation Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu 610041, ChinaNanodrug delivery systems have revolutionized tumor therapy like never before. By overcoming the complexity of the tumor microenvironment (TME) and bypassing drug resistance mechanisms, nanotechnology has shown great potential to improve drug efficacy and reduce toxic side effects. This review examines the impact of the TME on drug resistance and recent advances in nanomedicine delivery systems to overcome this challenge. Characteristics of the TME such as hypoxia, acidity, and high interstitial pressure significantly reduce the effectiveness of chemotherapy and radiotherapy, leading to increased drug resistance in tumor cells. Then, this review summarizes innovative nanocarrier designs for these microenvironmental features, including hypoxia-sensitive nanoparticles, pH-responsive carriers, and multifunctional nanosystems that enable targeted drug release and improved drug penetration and accumulation in tumors. By combining nanotechnology with therapeutic strategies, this review offers a novel perspective by focusing on the innovative design of nanocarriers that interact with the TME, a dimension often overlooked in similar reviews. We highlight the dual role of these nanocarriers in therapeutic delivery and TME modulation, emphasize their potential to overcome drug resistance, and look at future research directions.https://www.mdpi.com/1999-4923/16/12/1549nanomedicine deliverytumor microenvironmentdrug resistance
spellingShingle Wenjun Meng
Li Huang
Jiamin Guo
Qing Xin
Jiyan Liu
Yuzhu Hu
Innovative Nanomedicine Delivery: Targeting Tumor Microenvironment to Defeat Drug Resistance
Pharmaceutics
nanomedicine delivery
tumor microenvironment
drug resistance
title Innovative Nanomedicine Delivery: Targeting Tumor Microenvironment to Defeat Drug Resistance
title_full Innovative Nanomedicine Delivery: Targeting Tumor Microenvironment to Defeat Drug Resistance
title_fullStr Innovative Nanomedicine Delivery: Targeting Tumor Microenvironment to Defeat Drug Resistance
title_full_unstemmed Innovative Nanomedicine Delivery: Targeting Tumor Microenvironment to Defeat Drug Resistance
title_short Innovative Nanomedicine Delivery: Targeting Tumor Microenvironment to Defeat Drug Resistance
title_sort innovative nanomedicine delivery targeting tumor microenvironment to defeat drug resistance
topic nanomedicine delivery
tumor microenvironment
drug resistance
url https://www.mdpi.com/1999-4923/16/12/1549
work_keys_str_mv AT wenjunmeng innovativenanomedicinedeliverytargetingtumormicroenvironmenttodefeatdrugresistance
AT lihuang innovativenanomedicinedeliverytargetingtumormicroenvironmenttodefeatdrugresistance
AT jiaminguo innovativenanomedicinedeliverytargetingtumormicroenvironmenttodefeatdrugresistance
AT qingxin innovativenanomedicinedeliverytargetingtumormicroenvironmenttodefeatdrugresistance
AT jiyanliu innovativenanomedicinedeliverytargetingtumormicroenvironmenttodefeatdrugresistance
AT yuzhuhu innovativenanomedicinedeliverytargetingtumormicroenvironmenttodefeatdrugresistance